5 unknown, 3 completed, 3 withdrawn, 2 terminated. 13 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Unknown 5, Completed 3, Withdrawn 3, Terminated 2 |
| Phase 2 | 4 | Unknown 2, Terminated 1, Withdrawn 1 |
Follow Thoracic Injuries: new trials by email Literature Review of Thoracic Injuries trials Research Report on Thoracic Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultrasound Guided Emergency Physician Performed Erector Spinae Nerve Block for Rib Fracture Analgesia ESP block with bupivacaine, Saline control/sham injection - Rib Fractures | Phase 1 / Phase 2 | Withdrawn | Yale University | 2025-05-01 | 2025-07-01 | |
| Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases mesenchymal stem cells, saline - Lung Injury | Phase 1 / Phase 2 | Unknown | Cell Energy Life Sciences Group Co. LTD | 80 | 2023-05-10 | 2024-05-16 |
| Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury Lanadelumab, Saline control - Lung Injury | Phase 1 | Unknown | St Vincent's Institute of Medical Research | 48 | 2021-08-09 | 2024-04-17 |
| Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury human umbilical cord-derived mesenchymal stem cells, saline - Ischemic Heart Disease, Lung Injury | Phase 1 | Unknown | Shanghai East Hospital | 16 | 2021-08-01 | 2023-12-19 |
| RAPA-501-Allo Therapy of COVID-19-ARDS RAPA-501-Allo off-the-shelf Therapy of COVID-19, Placebo - Severe COVID-19 Disease | Phase 1 / Phase 2 | Terminated | Rapa Therapeutics LLC | 1 | 2020-12-30 | 2021-11-11 |
| CLBS119 for Repair of COVID-19 Induced Pulmonary Damage CLBS119 - Covid-19 | Phase 1 | Withdrawn | Lisata Therapeutics, Inc. | 2020-10-05 | 2024-10-09 | |
| The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients Ropivacaine, Normal Saline Flush, 0.9% Injectable Solution - Rib Fractures | Phase 1 | Terminated | Virginia Commonwealth University | 4 | 2019-05-24 | 2020-08-07 |
| Lung and Diaphragm-Protective Ventilation by Means of Assessing Respiratory Work Lung- and Diaphragm-Protective Ventilation - Diaphragm Injury, Lung Injury | Phase 1 | Completed | University Health Network, Toronto | 23 | 2019-02-01 | 2024-12-10 |
| Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury UCMSC group, Control group(Normal saline) - Paraquat Poisoning, Lung Injury | Phase 1 / Phase 2 | Unknown | Affiliated Hospital to Academy of Military Medical Sciences | 40 | 2015-05-01 | 2015-05-15 |
| Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP Heated Humidified High Flow Nasal Cannula, Nasal Continuous Positive Airway Pressure - Respiratory Distress, Lung Injury | Phase 1 | Withdrawn | Children's Hospital of Philadelphia | 2014-03-01 | 2015-09-15 | |
| A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Single IV dose of GSK2862277, Matching placebo single dose IV infusion, Single IH dose of GSK2862277 - Respiratory Disorders | Phase 1 | Completed | GlaxoSmithKline | 54 | 2013-02-22 | 2017-05-15 |
| Safety Study of Nebulized Sodium Nitroprusside in Adult Acute Lung Injury Sodium Nitroprusside - Acute Lung Injury, Acute Respiratory Distress Syndrome | Phase 1 | Unknown | Mount Sinai Hospital, Canada | 30 | 2012-05-01 | 2012-06-14 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 GSK1995057, bronchoalveolar lavage, LPS - Respiratory Disorders | Phase 1 | Completed | GlaxoSmithKline | 53 | 2012-03-28 | 2019-06-27 |
Lung Injury (11) · Respiratory Distress Syndrome (3) · Respiratory Insufficiency (3) · Acute Lung Injury (2) · COVID-19 (2) · Coronavirus Infections (2) · Lung Diseases (2) · Pneumonia (2) · Respiration Disorders (2) · Rib Fractures (2) · Cytokine Release Syndrome (1) · Dyspnea (1) · Hypoxia (1) · Infections (1) · Myocardial Ischemia (1)
Wounds and Injuries (13) · Respiratory Tract Diseases (10) · Lung Diseases (9) · Respiration Disorders (5) · Pathological Conditions, Signs and Symptoms (3) · Coronaviridae Infections (2) · Fractures, Bone (2) · Infections (2) · Nidovirales Infections (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2)
Sodium Chloride (3) · Anesthetics, Local (1) · Bronchoalveolar Lavage (1) · Bupivacaine (1) · Continuous Positive Airway Pressure (1) · GSK1995057 (1) · Infusions, Intravenous (1) · Nitroprusside (1) · Ropivacaine (1) · lanadelumab (1)
GlaxoSmithKline (2) · Affiliated Hospital to Academy of Military Medical Sciences (1) · Cell Energy Life Sciences Group Co. LTD (1) · Children's Hospital of Philadelphia (1) · Lisata Therapeutics, Inc. (1) · Mount Sinai Hospital, Canada (1) · Rapa Therapeutics LLC (1) · Shanghai East Hospital (1) · St Vincent's Institute of Medical Research (1) · University Health Network, Toronto (1) · Virginia Commonwealth University (1) · Yale University (1)
United States (4) · China (3) · Canada (2) · United Kingdom (2) · Australia (1)
Bing Liu, M.D. (1) · Bryant Tran, MD (1) · Chunyan Wang, M.D. (1) · Cristiana Baloescu, MD (1) · Daniel Fowler, M.D. (1) · Douglas W Losordo, MD (1) · Ewan Goligher, MD, PhD (1) · Haochun Wang, M.D. (1) · Sangeeta Mehta, MD FRCPC (1) · Soraya Abbasi, MD (1) · Terence Ip, MD (1) · Xiangrui Wang (1) · Xiaobo Peng, M.D. (1)